Spark Therapeutics

Spark Therapeutics

Verified
A fully integrated gene therapy company focused on inherited retinal diseases (IRDs), neurodegenerative diseases, as well as diseases that can be addressed by targeting the liver, such as hemophilia.

Financials

Estimates*

Get premium to view all results
Edit
Revenues, earnings & profits over time
EUR201620172018
Revenues000000000000
EBITDA000000000000
Profit000000000000
EV / revenue00.0x00.0x00.0x
EV / EBITDA00.0x00.0x00.0x
R&D budget000000000000

Source: Dealroom estimates

  • Edit
Get premium to view all results
DateInvestorsAmountRound
-investor

$0.0

round
investor

$0.0

round
N/A

$0.0

Valuation: $0.0

round
N/A

$0.0

round
N/A

$0.0

round
N/A

$0.0

round
*

$4.3b

Valuation: $4.3b

Acquisition
Total Funding000k

Recent News about Spark Therapeutics

Edit

Tech stack

Group
Tech stackLearn more about the technologies and tools that this company uses.
Book a Demo

Investments by Spark Therapeutics

Edit
Genable Technologies Ltd.
ACQUISITION by Spark Therapeutics Mar 2016